FDA Investigator Pushpa S Jayasekara
Pushpa S Jayasekara has inspections in 1 countries as of 27 Sep 2023. Pushpa S Jayasekara has collaborated with a combined 965 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
27 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alice S Tsao,
Ankur C Patel,
Barbara Jwilimczyk Macri,
Brenna L Macdowell,
Daniel J Grabicki,
Daniel J Min,
David A Oluwo,
Dien N Nguyen,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Frederick Razzaghi,
Helen Verdel,
James M Mason,
James R Birkenstamm,
James W Leonette,
Jay B Shah,
Jeanne D Shaffer,
Jogy George,
Jonah S Ufferfilge,
Jose M Cayuela,
Juan Rjimenez Garcia,
Justine Tomasso,
Karishma G Gopaul,
Kenneth Nieves,
Lata C Mathew, PhD,
Lauren L Vajo,
LCDR Chad N Thompson,
Lori M Newman,
Marcellinus D Dordunoo,
Marea K Harmon,
Margaret M Sands,
Michael R Klapal,
Michael Serrano,
Mindy M Chou,
Nancy M Espinal,
Natasha Gupta,
Nebil A Oumer,
Nicholas A Violand,
Niketa Patel,
Odera I Ekwunife,
Paul L Bellamy,
Puspa Suresh Jayasekara,
Rachael A Moliver,
Rachel C Harrington,
Robin P Mathew,
Rose Ljean Mary,
Russell J Glapioin,
Russell J Glapion,
Samir C Gala,
Stephanie L Shapley,
Tanya R Syffrard,
Unnee Ranjan,
Victoria Spivak
Pushpa S Jayasekara's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2023 | FDA 483 | Siegfried USA, LLC - Form 483, 2023-09-27 |
February, 2023 | FDA 483 | SriSai Biopharmaceutical Solutions, LLC - Form 483, 2023-02-23 |
August, 2022 | FDA 483 | APPCO PHARMA LLC - Form 483, 2022-08-19 |
November, 2022 | FDA 483 | ChiRhoClin, Inc - Form 483, 2022-11-03 |
June, 2023 | FDA 483 | SterRx, LLC - Form 483, 2023-06-28 |
January, 2023 | FDA 483 | Miyoshi America, Inc. - Form 483, 2023-01-13 |
March, 2023 | FDA 483 | FORDOZ PHARMA CORPORATION - Form 483, 2023-03-17 |
November, 2022 | FDA 483 | Amneal Pharmaceuticals, LLC - Form 483, 2022-11-18 |
November, 2023 | FDA 483 | WES PHARMA INC - Form 483, 2023-11-21 |
September, 2023 | EIR | Siegfried USA, LLC - EIR, 2023-10-26 |
August, 2023 | EIR | Advanced Accelerator Applications USA, Inc. - EIR, 2023-10-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more